A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
Clinical trial NCT04712734 · COMPLETED
Trial details
- NCT number
- NCT04712734
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2022-08-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.